Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mycosol-Plus is a multivitamin combination product developed by Boffin Biotech. It is formulated as an injection or tablet containing methylcobalamin (vitamin B12), pyridoxine hydrochloride (vitamin B6), niacinamide (vitamin B3), and D-panthenol (vitamin B5). This combination is primarily used to treat or prevent vitamin deficiencies, peripheral neuropathy, diabetic neuropathy, and other neuropathic conditions. Methylcobalamin acts as a cofactor for methionine synthase, which is essential for myelin sheath formation and nerve regeneration. Pyridoxine is crucial for amino acid metabolism and neurotransmitter synthesis. Niacinamide serves as a precursor to NAD+ and NADP+, supporting cellular energy production, while D-panthenol is a precursor to coenzyme A, which is vital for fatty acid synthesis and energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mycosol-Plus.